NOVEL SNP-ALLELE GENOTYPING METHOD

Information

  • Research Project
  • 6584027
  • ApplicationId
    6584027
  • Core Project Number
    R01HG002322
  • Full Project Number
    3R01HG002322-02S1
  • Serial Number
    2322
  • FOA Number
  • Sub Project Id
  • Project Start Date
    8/28/2000 - 23 years ago
  • Project End Date
    7/31/2003 - 20 years ago
  • Program Officer Name
    BROOKS, LISA
  • Budget Start Date
    4/18/2002 - 22 years ago
  • Budget End Date
    7/31/2002 - 21 years ago
  • Fiscal Year
    2002
  • Support Year
    2
  • Suffix
    S1
  • Award Notice Date
    4/15/2002 - 22 years ago
Organizations

NOVEL SNP-ALLELE GENOTYPING METHOD

1. Develop an efficient, low cost SNP genotyping system for experimental murine intercrosses. - A database for computational selection of genotyping primers will be established. Assays for 200 SNPs, with a known chromosomal location will be produced, and alleles in 10 inbred murine strains and two different mouse species will be characterized. - Two experimental murine intercross populations will be genotyped by this method. 2. Demonstrate that this method can accurately determine allele frequencies in pooled murine DNA samples, which will greatly accelerate complex train analysis in murine genetic models of human disease. DNA samples from phenotypically extreme F2 progeny (top or bottom 10%) will be pooled to form two groups, and genotyped to rapidly identify chromosomal regions regulating susceptibility to emphysema and polycystic kidney disease. 3. The accuracy and reproducibility of this method for pooled human DNA samples will be determined. To identify cardiovascular disease susceptibility genes, DNA samples from 1000 probands and 1000 case controls have been individually genotyped at 35 SNPs in 16 genes. The samples will be pooled into disease affected and control groups and allele frequencies in the pooled samples will be measured and compared to the results from genotyping individual samples. - The statistical significance of the measured differences, and the sensitivity of screening studies of this type to detect disease-associated polymorphisms will be assessed.

IC Name
NATIONAL HUMAN GENOME RESEARCH INSTITUTE
  • Activity
    R01
  • Administering IC
    HG
  • Application Type
    3
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    61000
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    172
  • Ed Inst. Type
  • Funding ICs
    NHGRI:61000\
  • Funding Mechanism
  • Study Section
    GNM
  • Study Section Name
    Genome Study Section
  • Organization Name
    ROCHE PALO ALTO, LLC
  • Organization Department
  • Organization DUNS
  • Organization City
    PALO ALTO
  • Organization State
    CA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    94304
  • Organization District
    UNITED STATES